• Angiotensin II Workflows for Vascular Research

  2026-08-21

  Build reproducible cell and animal models of vasoconstriction, hypertension, remodeling, and vascular smooth muscle cell hypertrophy with a sequence-defined endogenous peptide. This guide connects short exposure assays with telemetry-based chronic infusion studies and provides practical controls for sex-dependent response variability.

• IWP-2: A Cell-Aware Wnt Assay Strategy

  2026-08-20

  IWP-2 is a potent Wnt production inhibitor for dissecting PORCN-dependent Wnt/β-catenin biology. This article connects its cancer research applications with a cell-aware assay framework inspired by large-scale single-nucleus profiling of atrial fibrillation.

• SU5416: From VEGFR2 Tool to Model Variable

  2026-08-20

  SU5416 (Semaxanib) is more than a selective VEGFR2 inhibitor: its biological effect depends strongly on vascular context and species. This evidence-led guide explains how to use it for angiogenesis assays while avoiding misleading conclusions from pulmonary vascular models.

• RNase R (20 U/μL) for Circular RNA Enrichment

  2026-08-19

  Ribonuclease R is a processive 3′-to-5′ exoribonuclease used to reduce linear RNA and enrich intact circular RNA for downstream analysis. RNase R (20 U/μL), SKU K3061, is supplied with 10× RNase R Reaction Buffer and supports RNA structure analysis, RNA stability studies, and RNA metabolism workflows.

• Losartan and AT1R Trafficking in Diabetic Nephropathy

  2026-08-19

  Losartan is more than an angiotensin II receptor antagonist for blood-pressure models: it can help resolve how AT1R signaling and receptor trafficking shape renal matrix biology. This article translates recent GPR107–AT1R findings into practical assay decisions for hypertension research and cardiovascular physiology study design.

• 3X FLAG Peptide for VPS13A–XK Studies

  2026-08-18

  The 3X (DYKDDDDK) Peptide provides a practical detection and purification handle for recombinant protein studies. This article connects FLAG-tag workflow design with the VPS13A–XK lipid-transfer mechanism while clarifying assay opportunities, metal-related controls, and experimental limitations.

• HDV Genotype Responses to Interferon-Alpha

  2026-08-18

  The reference study distinguishes how HDV genotype, cellular state, interferon-alpha subtype, and ADAR1 isoform influence antiviral activity. Its findings suggest that interferon-based treatment should account for both viral spread strategy and host-cell context, while selected interferon subtypes may be useful partners for bulevirtide.

• SFRP1, Wnt/β-Catenin, and Oral Fibrosis

  2026-08-17

  A 2024 study used an arecoline-induced mouse model and complementary cell experiments to show that SFRP1 reduces neutrophil infiltration and oral submucous fibrosis while suppressing Wnt/β-catenin signaling. The work links immune-cell recruitment with fibrotic pathway activity and provides a mechanistic framework for evaluating pathway-directed interventions in oral fibrosis.

• Minocycline HCl for Retinal Microglia Assays

  2026-08-17

  Use Minocycline HCl as a pharmacologic microglial-activity control when testing 40-Hz flicker, amyloid-β clearance, and retinal function. This workflow separates its antimicrobial mechanism from its anti-inflammatory and neuroprotective effects, helping researchers interpret MHC-II, imaging, and functional readouts with greater confidence.

• Losartan: AT1R Trafficking in Vascular Assays

  2026-08-16

  Losartan is an angiotensin II receptor antagonist that can do more than suppress receptor signaling: it can help researchers distinguish AT1R activation from receptor-trafficking defects. This article develops a trafficking-aware framework for hypertension research, vascular smooth muscle cell assays, and mechanistic interpretation of diabetic nephropathy models.

• Imipramine as a Translational Autophagy Probe

  2026-08-15

  Imipramine, a tricyclic antidepressant with reported autophagy and apoptosis effects, offers translational researchers a pharmacological entry point for studying cell-state regulation. This article connects cancer-focused assays with ceramide-driven autophagy findings in fish nodavirus infection while clearly separating established evidence from exploratory hypotheses.

• IFN-γ as a Lens on MASH-HCC Immunity

  2026-08-15

  MASH-HCC research is revealing that metabolic stress can suppress tumor antigen presentation before immune checkpoint blockade has a chance to work. This thought-leadership guide explains how Recombinant Mouse IFN-γ can function as a controlled mechanistic probe for testing MHC-I competence, separating tumor-intrinsic immune escape from downstream immune-cell failure, and strengthening translational assay design.

• Palonosetron Hydrochloride: From Mechanism to Translation

  2026-08-14

  Palonosetron hydrochloride is a highly selective 5-HT3 receptor antagonist whose sustained receptor engagement connects molecular pharmacology with chemotherapy-induced nausea and vomiting prevention, radiotherapy-induced nausea and vomiting prevention, and translational cancer research. This article outlines assay strategy, renal transporter considerations, competitive differentiation, and practical study design.

• Angiotensin II in AAA Mechanism Studies

  2026-08-13

  Angiotensin II is more than a vasopressor: it is a controlled receptor-level perturbation for dissecting vascular remodeling and aneurysm biology. This article shows how to pair Angiotensin II assays with the cross-scale environmental findings reported in a 2026 Environment International study without confusing correlation with causation.

• Alda 1 and the Translational Logic of ALDH2

  2026-08-13

  A mechanistic and strategic guide to using Alda 1 as an ALDH2 activator in cardiac ischemia research, aldehyde detoxification, cardiomyocyte proliferation, and related preclinical injury models.

449 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page